Epistem Limited

disease & therapeutic research models

Inflammatory Bowel Disease

GI Toxicity and Mucositis

Immune Cell Assays

Rheumatoid Arthritis

services

Gene Expression Analysis

Histology and IHC Services

Laser Capture Microdissection

Analytical Services

Plucked Hair Analysis

Spotlight On...

Fibrosis and COVID-19
Researchers have identified a unique COVID-19 signature in the lung, the mechanisms of which are contributors towards…
Correlation between Gastric Cancer Transcriptome and Histotype Demonstrates …
In this study, researchers identified biomarkers for intestinal and diffuse gastric cancer which could be targets for…
Integrative RNA-Seq and ChIP-Seq Analysis of Human Lung Cancer Cells Isolated …
A study looking at the development of a workflow for integrative RNA-sequencing (RNA-Seq) and chromatin immunoprecipitation sequencing (ChIP-Seq)…
SIRT1 Inhibitors Mitigate Radiation-Induced GI Syndrome by Enhancing Intestinal …
In this study, the authors demonstrated that SIRT1 inhibitors were able to mitigate some of the effects of acute radiation exposure. SIRT1 inhibitors…
Heterogeneous cellular response to ionising radiation revealed by single cell …
In this study, the authors used single-cell transcriptomic analysis to determine the effects of ionising radiation in a breast cancer cell line.…

Announcements

NEWS: Epistem licence Hubrecht Organoid Technology to expand preclinical toxicology service portfolio
2019-07-15
Epistem Limited has announced the expansion of its in vitro model portfolio by the completion of an agreement with Hubrecht Organoid Technology (HUB)…
NEWS: 10 Years GCLP Accreditation at Epistem
2019-01-11
We are pleased to announce the successful GCLP re-accreditation of our laboratories.

© 2018, 2021 Epistem Ltd.

site map | privacy policy | terms of use | contact us

Call us on +44 (0)161 850 7600 or email info@epistem.co.uk

Accelerating Drug Development with Innovative Services

This site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this again